Review Manager v 5.4 software was used for statistical evaluation of data.<h4>Results</h4>Overall 6 studies with 843 HER-2 positive breast cancer patients (442 HER-2 amplified disease, 399 luminal B disease) were included in this systematic review and meta-analysis. Here, ERBB2 is linked to breast carcinoma.